Wegovy (semaglutide) is an injectable medication that is used with a reduced-calorie diet and increased exercise to help manage chronic weight in adults who are: Obese (body mass index = 30 kg/m2) OR Overweight (body mass index = 27 kg/m2) with at least one weight-related condition (e.g., high blood pressure, diabetes, high cholesterol) Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist
If you rely on the medication alone, you may lose weight, but keeping it off long-term will be much harder
Bland foods like rice, crackers, bananas, and toast tend to sit better during the adjustment
Before prescribing liraglutide, well meet with you to determine whether its appropriate for your situation
Date: March 19, 2026 Source: Cleveland Clinic Summary: Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear
Semaglutide can also address health issues linked to obesity and diabetes, such as an elevated risk of heart attacks or stroke